|
|
| | 2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid,2-(2-hydroxyethylamino)ethanol Basic information |
| Product Name: | 2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid,2-(2-hydroxyethylamino)ethanol | | Synonyms: | 2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid,2-(2-hydroxyethylamino)ethanol;Treprostinil Diethanolamine(UT 15C);treprostinil diethanolamine salt;UT-15C;Treprostinil Impurity 7;Acetic acid,[[(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl]oxy]-, compd. with 2,2'-iminobis[ethanol](1:1);Treprostinil Diolamine;Treprostinil diethanolamine | | CAS: | 830354-48-8 | | MF: | C27H45NO7 | | MW: | 495.66 | | EINECS: | | | Product Categories: | | | Mol File: | 830354-48-8.mol | ![2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid,2-(2-hydroxyethylamino)ethanol Structure](CAS/20180601/GIF/830354-48-8.gif) |
| | 2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid,2-(2-hydroxyethylamino)ethanol Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMF: 20 mg/ml,DMSO: 5 mg/ml,Ethanol: 13 mg/ml,PBS (pH 7.2): 5 mg/ml | | form | A crystalline solid | | InChIKey | RHWRWEUCEXUUAV-JZKGKPKXNA-N | | SMILES | N(CCO)CCO.C([C@H]1[C@@H](C[C@]2([H])CC3=C(C=CC=C3C[C@]12[H])OCC(=O)O)O)C[C@@H](O)CCCCC |&1:8,9,11,21,30,r| |
| | 2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid,2-(2-hydroxyethylamino)ethanol Usage And Synthesis |
| Uses | Treprostinil Diolamine is a sustained-release oral formulation of Treprostinil (T719500) and was studied to determine whether it could provide a more convenient prostacyclin treatment option for patients with less severe pulmonary arterial hypertension.Treprostinil Diolamine is an sustained-release oral prostacyclin analog and was studied to determine pharmacokinetic profile in PAH patients after chronic dosing, |
| | 2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid,2-(2-hydroxyethylamino)ethanol Preparation Products And Raw materials |
|